|
KCTD21 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.15400000003196E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67939999995426E-06 |
| Normal-vs-Stage2 |
5.336500E-03 |
| Normal-vs-Stage3 |
2.378700E-03 |
| Normal-vs-Stage4 |
2.44949999999022E-05 |
| Stage1-vs-Stage2 |
4.757800E-01 |
| Stage1-vs-Stage3 |
3.588600E-01 |
| Stage1-vs-Stage4 |
5.362300E-02 |
| Stage2-vs-Stage3 |
9.481400E-01 |
| Stage2-vs-Stage4 |
6.644300E-02 |
| Stage3-vs-Stage4 |
2.713700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.01500000004862E-06 |
| Normal-vs-AfricanAmerican |
8.02360000000668E-05 |
| Normal-vs-Asian |
1.124410E-01 |
| Caucasian-vs-AfricanAmerican |
5.153400E-01 |
| Caucasian-vs-Asian |
5.563600E-01 |
| AfricanAmerican-vs-Asian |
4.992600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.09340000387093E-08 |
| Normal-vs-Female |
5.800800E-03 |
| Male-vs-Female |
1.998080E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.015900E-04 |
| Normal-vs-Extreme_Weight |
2.97980529140318E-11 |
| Normal-vs-Obese |
8.384400E-04 |
| Normal-vs-Extreme_Obese |
3.781800E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.467600E-01 |
| Normal_Weight-vs-Obese |
2.454600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.577200E-01 |
| Extreme_Weight-vs-Obese |
4.615900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.039800E-01 |
| Obese-vs-Extreme_Obese |
9.848200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.340100E-02 |
| Normal-vs-Age(41-60Yrs) |
7.633800E-04 |
| Normal-vs-Age(61-80Yrs) |
2.53599999888721E-08 |
| Normal-vs-Age(81-100Yrs) |
4.995000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.961000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.136200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.632620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.665900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.696400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.946200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.88139995091785E-09 |
| Normal-VS-Type2 PRCC |
2.018800E-03 |
| Normal-VS-KIRP CIMP |
1.931160E-01 |
| Normal-VS-Unclassified PRCC |
2.060300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.676200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.153900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.231800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.311800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.393000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.895600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.19409999999898E-05 |
| Normal-vs-N1 |
3.875100E-03 |
| Normal-vs-N2 |
8.975600E-03 |
| N0-vs-N1 |
5.530200E-01 |
| N0-vs-N2 |
4.535200E-01 |
| N1-vs-N2 |
3.375400E-01 |
|
|
